> top > docs > PMC:7205724 > spans > 168-530 > annotations

PMC:7205724 / 168-530 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 84-91 Species denotes patient Tax:9606
5 163-171 Disease denotes COVID-19 MESH:C000657245
7 246-254 Disease denotes COVID-19 MESH:C000657245
10 259-262 Gene denotes IL6 Gene:3569
11 331-339 Disease denotes COVID-19 MESH:C000657245
20 344-355 Chemical denotes Tocilizumab MESH:C502936

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 163-171 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 246-254 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 331-339 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T3 53-68 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T4 116-131 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T5 226-241 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 302-312 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 53-68 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T3 116-131 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T4 226-241 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 163-171 Species denotes COVID-19 NCBItxid:2697049
T3 246-254 Species denotes COVID-19 NCBItxid:2697049
T4 331-339 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T4 2-12 Sentence denotes Highlights
T5 13-101 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
T6 102-172 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.
T7 173-255 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.
T8 256-340 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
3 84-91 Species denotes patient Tax:9606
5 163-171 Disease denotes COVID-19 MESH:C000657245
7 246-254 Disease denotes COVID-19 MESH:C000657245
10 259-262 Gene denotes IL6 Gene:3569
11 331-339 Disease denotes COVID-19 MESH:C000657245
20 344-355 Chemical denotes Tocilizumab MESH:C502936

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 259-262 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T23 2-12 NNS denotes Highlights
T24 13-14 IN denotes •
T25 16-20 NNP denotes IVIG
T26 20-21 -COMMA- denotes ,
T27 22-30 VBN denotes combined
T28 31-35 IN denotes with
T29 36-49 NN denotes moderate-dose
T30 50-52 IN denotes of
T31 53-68 NNS denotes corticosteroids
T32 68-69 -COMMA- denotes ,
T33 70-75 MD denotes might
T34 76-83 VB denotes improve
T35 84-91 NN denotes patient
T36 92-100 NNS denotes outcomes
T37 102-103 PDT denotes •
T38 105-108 DT denotes The
T39 109-112 NN denotes use
T40 113-115 IN denotes of
T41 116-131 NNS denotes corticosteroids
T42 132-137 MD denotes might
T43 138-148 VB denotes accelerate
T44 149-157 NN denotes recovery
T45 158-162 IN denotes from
T46 163-171 NN denotes COVID-19
T47 173-174 PDT denotes •
T48 176-178 DT denotes No
T49 179-189 VBN denotes controlled
T50 190-198 JJ denotes clinical
T51 199-205 NNS denotes trials
T52 206-211 VBP denotes exist
T53 212-214 IN denotes on
T54 215-218 DT denotes the
T55 219-222 NN denotes use
T56 223-225 IN denotes of
T57 226-241 NNS denotes corticosteroids
T58 242-245 IN denotes for
T59 246-254 NN denotes COVID-19
T60 256-257 LS denotes •
T61 259-262 NN denotes IL6
T62 263-273 VBZ denotes correlates
T63 274-278 IN denotes with
T64 279-287 NN denotes severity
T65 287-288 -COMMA- denotes ,
T66 289-300 NN denotes criticality
T67 300-301 -COMMA- denotes ,
T68 302-307 JJ denotes viral
T69 308-312 NN denotes load
T70 312-313 -COMMA- denotes ,
T71 314-317 CC denotes and
T72 318-327 NN denotes prognosis
T73 328-330 IN denotes of
T74 331-339 NN denotes COVID-19
T75 341-342 IN denotes •
T76 344-355 NNP denotes Tocilizumab
T77 355-356 -COMMA- denotes ,
T78 357-359 DT denotes an
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R70 T76 T77 arg1Of Tocilizumab,","

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 163-171 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 246-254 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 331-339 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 2-12 Sentence denotes Highlights
T5 13-101 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
T6 102-172 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.
T7 173-255 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.
T8 256-340 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.